Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
insulin glargine (toujeo) (4 trials)
insulin lispro (humalog) (2 trials)
glr2007 (1 trial)
insulin aspart (novolog) (1 trial)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Diabetes Mellitus (Phase 3)
Diabetes Mellitus, Type 1 (Phase 3)
Diabetes Mellitus, Type 2 (Phase 3)
Glioblastoma (Phase 2)
Trials (8 total)
Trial APIs (4 total)